AddLife AB (publ) (LON:0REZ)

Market Cap	1.30B -4.3%
Revenue (ttm)	841.73M +1.5%
Net Income	45.14M +122.2%
EPS	0.37 +122.8%
Shares Out	n/a
PE Ratio	28.89
Forward PE	30.57
Dividend	0.06 (0.04%)
Ex-Dividend Date	May 9, 2025

Volume	1,045
Average Volume	2,578
Open	136.40
Previous Close	136.34
Day's Range	134.60 - 137.50
52-Week Range	133.70 - 207.60
Beta	1.79
RSI	38.04
Earnings Date	Apr 1, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,295
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK